Other
30% glucose
30% glucose is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
25%
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (25.0%)
N/A3 (75.0%)
Trials by Status
completed375%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
unknownnot_applicable
Analgesic Effect of Oral Glucose in Neonates
NCT04467177
completednot_applicable
Oral Glucose in Pain Alleviation Among Term Neonates
NCT03190980
completednot_applicable
Oral Sweet Solution to Prevent Pain During Neonatal Hip Examination
NCT03486015
completedphase_3
Intraoral 30% Glucose Effect In Newborns
NCT02325583
Clinical Trials (4)
Showing 4 of 4 trials
NCT04467177Not Applicable
Analgesic Effect of Oral Glucose in Neonates
NCT03190980Not Applicable
Oral Glucose in Pain Alleviation Among Term Neonates
NCT03486015Not Applicable
Oral Sweet Solution to Prevent Pain During Neonatal Hip Examination
NCT02325583Phase 3
Intraoral 30% Glucose Effect In Newborns
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4